Takeda Pharmaceutical (TAK) Share-based Compensation (2018 - 2026)
Takeda Pharmaceutical (TAK) recorded Share-based Compensation of $114.12 million in the quarter ended Jun 30, 2026, down 0.1% from $114.25 million a year earlier and down 9.2% from the prior quarter.
Takeda Pharmaceutical (TAK) Share-based Compensation (2018 - 2026) Analysis & Trends
On a TTM basis, Takeda Pharmaceutical's Share-based Compensation came in at $482.61 million as of Jun 30, 2026, down 2.4% year-over-year; for the year ended Mar 31, 2026, it came in at $483.46 million, up 1.1% from the prior year.
- Annual Share-based Compensation has a five-year compound annual growth rate of 6.4% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Share-based Compensation came in at $478.36 million in the year ended Mar 31, 2025 (-2.7%), $491.43 million in the year ended Mar 31, 2024 (+9.4%), $449.11 million in the year ended Mar 31, 2023 (+16.2%) and $386.33 million in the year ended Mar 31, 2022 (+8.7%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Share-based Compensation since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Share-based Compensation rose in three of the last eight quarters, with growth averaging 1.3%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 18.6% in the quarter ended Jun 30, 2023, against a decline of 12.3% in the quarter ended Jun 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $125.69 million (quarter ended Mar 31, 2026), $115.68 million (quarter ended Dec 31, 2025) and $127.12 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 114.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.12 Mn |
| Mar 31, 2026 | 125.69 Mn |
| Dec 31, 2025 | 115.68 Mn |
| Sep 30, 2025 | 127.12 Mn |
| Jun 30, 2025 | 114.25 Mn |
| Mar 31, 2025 | 115.54 Mn |
| Dec 31, 2024 | 120.37 Mn |
| Sep 30, 2024 | 144.50 Mn |
| Jun 30, 2024 | 98.84 Mn |
| Mar 31, 2024 | 122.73 Mn |
| Dec 31, 2023 | 126.55 Mn |
| Sep 30, 2023 | 128.34 Mn |
| Jun 30, 2023 | 112.68 Mn |
| Mar 31, 2023 | 112.26 Mn |
| Dec 31, 2022 | 116.71 Mn |
| Sep 30, 2022 | 123.40 Mn |
| Jun 30, 2022 | 95.05 Mn |
| Jun 30, 2021 | 78.08 Mn |
| Mar 31, 2021 | 90.17 Mn |
| Jun 30, 2020 | 93.38 Mn |
Takeda Pharmaceutical Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();